Alveolus Bio

Biotechnology Research • Boston, Massachusetts, United States • 1-10 Employees

Company overview

Headquarters	Boston, Massachusetts, United States
Website	alveolusbio.com
NAICS	541714
Employees	1-10
Socials

Key Contacts at Alveolus Bio

Teodora Thea Nicola

Director Of Laboratory Research

Teodora Nicola

Senior Director Of Research And Laboratory Services

Alveolus Bio Email Formats

Alveolus Bio uses 2 email formats. The most common is {first initial} (e.g., j@alveolusbio.com), used 83.3% of the time.

Format	Example	Percentage
{first initial}	j@alveolusbio.com	83.3%
{first name}	john@alveolusbio.com	16.7%

About Alveolus Bio

Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases. Our pipeline includes preclinical stage live biotherapeutics for Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), and Non-Cystic Fibrosis Bronchiectasis (NCFBE). Inhaled delivery effectively targets the distal regions of the lungs, bypassing first-pass metabolism and enhancing efficacy while reducing adverse effects, differentiating our drugs from other treatments.

Alveolus Bio revenue & valuation

Annual revenue	$684,440
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,200,000
Total funding	$2,000,000